Retraction notices

Proteasome Inhibition Blocks NF-KappaB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

Type
Retraction
Notice date
5/1/2017 0:00
Journal
Molecular Cancer Therapeutics
Publisher
American Association for Cancer Research
Notice DOI
10.1158/1535-7163.mct-17-0084
Original paper DOI
10.1158/1535-7163.mct-11-0814

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.